Jin Yang Pharmaceutical Co., Ltd. (KOSDAQ:007370)
4,700.00
+70.00 (1.51%)
At close: Mar 6, 2026
Jin Yang Pharmaceutical Ratios and Metrics
Market cap in millions KRW. Fiscal year is January - December.
Millions KRW. Fiscal year is Jan - Dec.
Fiscal Year | Current | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2019 - 2015 |
|---|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 5, 2026 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2019 - 2015 |
| Market Capitalization | 58,290 | 66,504 | 66,805 | 70,257 | 78,689 | 78,242 | Upgrade
|
| Market Cap Growth | -22.66% | -0.45% | -4.91% | -10.72% | 0.57% | 59.09% | Upgrade
|
| Enterprise Value | 130,926 | 148,150 | 73,349 | 78,626 | 79,706 | 80,961 | Upgrade
|
| Last Close Price | 4515.00 | 5652.12 | 5859.13 | 6021.93 | 6356.42 | 6228.17 | Upgrade
|
| PE Ratio | 9.71 | 2.24 | 5.41 | 5.71 | 8.25 | 14.96 | Upgrade
|
| PS Ratio | 0.50 | 0.59 | 0.71 | 0.92 | 1.25 | 1.58 | Upgrade
|
| PB Ratio | 0.46 | 0.56 | 0.75 | 0.91 | 1.21 | 1.62 | Upgrade
|
| P/TBV Ratio | 0.48 | 0.58 | 0.80 | 0.95 | 1.24 | 1.67 | Upgrade
|
| P/FCF Ratio | 45.77 | - | 8.51 | 16.61 | - | 16.03 | Upgrade
|
| P/OCF Ratio | 20.63 | 5.20 | 7.83 | 9.43 | 39.93 | 12.53 | Upgrade
|
| EV/Sales Ratio | 1.12 | 1.31 | 0.78 | 1.03 | 1.27 | 1.64 | Upgrade
|
| EV/EBITDA Ratio | 12.61 | 10.79 | 6.47 | 5.86 | 8.74 | 12.83 | Upgrade
|
| EV/EBIT Ratio | 15.46 | 12.65 | 8.45 | 7.06 | 11.45 | 19.00 | Upgrade
|
| EV/FCF Ratio | 102.80 | - | 9.34 | 18.59 | - | 16.59 | Upgrade
|
| Debt / Equity Ratio | 0.61 | 0.67 | 0.09 | 0.26 | 0.31 | 0.13 | Upgrade
|
| Debt / EBITDA Ratio | 7.44 | 5.80 | 0.69 | 1.49 | 2.20 | 0.97 | Upgrade
|
| Debt / FCF Ratio | 60.65 | - | 1.00 | 4.72 | - | 1.26 | Upgrade
|
| Net Debt / Equity Ratio | 0.57 | 0.65 | -0.01 | 0.12 | 0.08 | 0.02 | Upgrade
|
| Net Debt / EBITDA Ratio | 7.00 | 5.66 | -0.07 | 0.71 | 0.56 | 0.13 | Upgrade
|
| Net Debt / FCF Ratio | 57.03 | -1.00 | -0.10 | 2.24 | -9.41 | 0.17 | Upgrade
|
| Asset Turnover | 0.51 | 0.65 | 0.80 | 0.72 | 0.74 | 0.71 | Upgrade
|
| Inventory Turnover | 2.75 | 2.72 | 2.24 | 2.50 | 3.41 | 3.19 | Upgrade
|
| Quick Ratio | 0.34 | 1.44 | 1.24 | 0.98 | 1.16 | 1.11 | Upgrade
|
| Current Ratio | 0.52 | 2.19 | 1.96 | 1.50 | 1.51 | 1.55 | Upgrade
|
| Return on Equity (ROE) | 4.48% | 28.46% | 14.84% | 17.23% | 16.79% | 11.38% | Upgrade
|
| Return on Assets (ROA) | 2.31% | 4.21% | 4.63% | 6.54% | 5.12% | 3.81% | Upgrade
|
| Return on Invested Capital (ROIC) | 3.56% | 6.57% | 9.92% | 11.98% | 9.16% | 7.07% | Upgrade
|
| Return on Capital Employed (ROCE) | 5.90% | 5.60% | 9.10% | 13.30% | 9.80% | 8.00% | Upgrade
|
| Earnings Yield | 9.45% | 44.65% | 18.47% | 17.52% | 12.12% | 6.68% | Upgrade
|
| FCF Yield | 2.19% | -116.19% | 11.75% | 6.02% | -0.69% | 6.24% | Upgrade
|
| Payout Ratio | 31.12% | 5.45% | 13.10% | 9.08% | 11.72% | 21.38% | Upgrade
|
| Buyback Yield / Dilution | 5.70% | 1.17% | 7.18% | -17.77% | -2.12% | - | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.